Skip to content

Application of intelligent diet management system in nutritional assessment and nutritional intervention of patients with ulcerative colitis

Application of intelligent diet management system in nutritional assessment and nutritional intervention of patients with ulcerative colitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064641
Enrollment
Unknown
Registered
2022-10-13
Start date
2022-10-25
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

UC(ulcerative colitis)

Interventions

Health education and diet guidance group (smart diet management system):Health education+personalized diet
Health education group:Health education

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of UC in the consensus opinions on the diagnosis and treatment of inflammatory bowel disease (2018 Beijing), patients in remission; 2. At risk of malnutrition; 3. Aged between 18 and 75 years; 4. Clear awareness and language communication; 5. The patient gave informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver, lung and kidney diseases; 2. Patients with diabetes and tumor; 3. Patients with UC complications and abdominal surgery history; 4. Pregnant and lactating patients; 5. Recent patients with colonic infectious inflammation such as intestinal tuberculosis, Crohn's disease, bacillary dysentery and parasitic infection, or with a history of probiotics, hormones, antibiotics and immunosuppressive drugs one month before treatment; 6. Patients with other autoimmune diseases; 7. Daily intake of enteral nutrition preparations, vitamin supplements and any other population that may affect microbiome analysis; 8. Unable to cooperate with the investigator.

Design outcomes

Primary

MeasureTime frame
Quality of life scale;

Secondary

MeasureTime frame
Sf-16 scale;Weight;Triceps skinfold thickness;Upper arm circumference;Body composition analysis;Hemoglobin;Serum albumin;Prealbumin;Hypersensitive C-reactive protein;Inflammatory factor;

Countries

China

Contacts

Public ContactLiyong Chen

Qilu Hospital of Shandong University

chenle73@sina.com+86 18560085613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026